Search research articles
Contact Us
Filters
Showing results (261-270 of 352) with videos related to
Page
of 36
Sort By:
The Journal of Antimicrobial Chemotherapy
|
February 1, 1994
In-vitro activity of five beta-lactam/beta-lactamase inhibitor combinations against consecutive isolates of the Enterobacteriaceae and Pseudomonas aeruginosa
J C McLaughlin, A L Barry, P C Fuchs, et al.
Diagnostic Microbiology and Infectious Disease
|
March 1, 1995
Comparative antimicrobial activity of piperacillin-tazobactam tested against more than 5000 recent clinical isolates from five medical centers. A reevaluation after five years
S A Marshall, K E Aldridge, S D Allen, et al.
Journal of Clinical Microbiology
|
May 1, 1992
MIC and disk diffusion quality control guidelines for Neisseria gonorrhoeae susceptibility tests of cefdinir, cefetamet, CI-960, fleroxacin, lomefloxacin, and temafloxacin
M E Erwin, R N Jones, F P Koontz, et al.
Antimicrobial Agents and Chemotherapy
|
December 1, 1986
Antimicrobial activity of Ro 15-8074, active metabolite of a new oral cephalosporin (Ro 15-8075), against 7,775 recent clinical isolates
R N Jones, P C Fuchs, A L Barry, et al.
Multiple Sclerosis and Related Disorders
|
December 6, 2021
Ultra-high field spinal cord MRI in multiple sclerosis: Where are we standing? A literature review
Daniël J Kreiter, Job van den Hurk, Christopher J Wiggins, et al.
Seminars in Thrombosis and Hemostasis
|
January 1, 1993
Aprotinin in orthotopic liver transplantation
W O Bechstein, H Riess, G Blumhardt, et al.
Behavioural Brain Research
|
November 9, 2018
Physically active life style is associated with increased grey matter brain volume in a medial parieto-frontal network
K M Eyme, M Domin, F H Gerlach, et al.
Diagnostic Microbiology and Infectious Disease
|
May 1, 1987
RO 23-6240 (AM-833), a new fluoroquinolone: in vitro antimicrobial activity and tentative disk diffusion interpretive criteria
P C Fuchs, R N Jones, A L Barry, et al.
Diagnostic Microbiology and Infectious Disease
|
May 1, 1987
Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid
A L Barry, T L Gavan, R N Jones, et al.
Diagnostic Microbiology and Infectious Disease
|
July 1, 1986
In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility testing criteria
P C Fuchs, R N Jones, A L Barry, et al.
Page
of 36
Search research articles
Search
Showing results (261-270 of 352) with videos related to
Sort By:
Page
of 36
The Journal of Antimicrobial Chemotherapy
|
February 1, 1994
In-vitro activity of five beta-lactam/beta-lactamase inhibitor combinations against consecutive isolates of the Enterobacteriaceae and Pseudomonas aeruginosa
J C McLaughlin, A L Barry, P C Fuchs, et al.
Diagnostic Microbiology and Infectious Disease
|
March 1, 1995
Comparative antimicrobial activity of piperacillin-tazobactam tested against more than 5000 recent clinical isolates from five medical centers. A reevaluation after five years
S A Marshall, K E Aldridge, S D Allen, et al.
Journal of Clinical Microbiology
|
May 1, 1992
MIC and disk diffusion quality control guidelines for Neisseria gonorrhoeae susceptibility tests of cefdinir, cefetamet, CI-960, fleroxacin, lomefloxacin, and temafloxacin
M E Erwin, R N Jones, F P Koontz, et al.
Antimicrobial Agents and Chemotherapy
|
December 1, 1986
Antimicrobial activity of Ro 15-8074, active metabolite of a new oral cephalosporin (Ro 15-8075), against 7,775 recent clinical isolates
R N Jones, P C Fuchs, A L Barry, et al.
Multiple Sclerosis and Related Disorders
|
December 6, 2021
Ultra-high field spinal cord MRI in multiple sclerosis: Where are we standing? A literature review
Daniël J Kreiter, Job van den Hurk, Christopher J Wiggins, et al.
Seminars in Thrombosis and Hemostasis
|
January 1, 1993
Aprotinin in orthotopic liver transplantation
W O Bechstein, H Riess, G Blumhardt, et al.
Behavioural Brain Research
|
November 9, 2018
Physically active life style is associated with increased grey matter brain volume in a medial parieto-frontal network
K M Eyme, M Domin, F H Gerlach, et al.
Diagnostic Microbiology and Infectious Disease
|
May 1, 1987
RO 23-6240 (AM-833), a new fluoroquinolone: in vitro antimicrobial activity and tentative disk diffusion interpretive criteria
P C Fuchs, R N Jones, A L Barry, et al.
Diagnostic Microbiology and Infectious Disease
|
May 1, 1987
Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid
A L Barry, T L Gavan, R N Jones, et al.
Diagnostic Microbiology and Infectious Disease
|
July 1, 1986
In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility testing criteria
P C Fuchs, R N Jones, A L Barry, et al.
Page
of 36